FDA.reportPublic FDA data

Myrbetriq 8 MG/ML 24 HR Extended Release Suspension

RxCUI
2541237
RxNorm name
Myrbetriq 8 MG/ML 24 HR Extended Release Suspension
Display name
Myrbetriq 8 MG/ML 24 HR Extended Release Suspension
Full name
Myrbetriq 8 MG/ML 24 HR Extended Release Suspension
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:18

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
MyrbetriqMIRABEGRONAstellas Pharma US, Inc.ba9e9e15-e666-4c56-9271-2e24739cfa2d2024-08-01Warnings, Adverse reactionsExact identifier
rxcui: 2541237

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
ba9e9e15-e666-4c56-9271-2e24739cfa2dMyrbetriq Granules 8 MG/mL 24HR Extended Release Suspension [PSN] · 24 HR mirabegron 8 MG/ML Extended Release Suspension [Myrbetriq] [SBD] · 24 HR Myrbetriq 8 MG/ML Extended Release Suspension [SY] · Myrbetriq 8 MG/ML 24 HR Extended Release Suspension [SY]417These highlights do not include all the information needed to use MYRBETRIQ ® /MYRBETRIQ ® GRANULES safely and effectively. See full prescribing information for MYRBETRIQ/MYRBETRIQ GRANULES. MYRBETRIQ (mirabegron extended-release tablets), for oral use MYRBETRIQ GRANULES (mirabegron for extended-release oral suspension) Initial U.S. Approval: 201220240801